End-of-day quote
Other stock markets
|
||
- USD | - |
Jul. 09 | Aspira Women's Health Inc. announced that it has received $1.910249 million in funding | CI |
Jul. 02 | Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Ahead of Powell Speech | MT |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Bio-analytic and Diagnostic Services
100.0
%
| 8 | 100.0 % | 9 | 100.0 % | +11.85% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 8 | 100.0 % | 9 | 100.0 % | +11.85% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Nicole Sandford
CEO | Chief Executive Officer | 54 | 21-02-21 |
Sandra Milligan
PSD | President | 60 | Mar. 31 |
Chief Operating Officer | - | - | |
Chief Tech/Sci/R&D Officer | - | 18-09-30 | |
Michelle Snider
PRN | Corporate Officer/Principal | - | 23-08-27 |
Diane Powis
PRN | Corporate Officer/Principal | - | 20-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ellen Vos
BRD | Director/Board Member | 68 | 23-05-08 |
Director/Board Member | 58 | 23-05-08 | |
Jannie Herchuk
CHM | Chairman | 61 | 23-05-08 |
Winfred Parnell
BRD | Director/Board Member | 71 | 23-05-31 |
Nicole Sandford
CEO | Chief Executive Officer | 54 | 21-02-21 |
Celeste Fralick
BRD | Director/Board Member | 68 | 22-02-22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 12,449,512 | 7,619,753 ( 61.21 %) | 0 | 61.21 % |
Company contact information
Aspira Women's Health, Inc.
12117 Bee Caves Road Suite 100
78738, Austin
+512 519 0400
http://www.vermillion.comSector
1st Jan change | Capi. | |
---|---|---|
-34.83% | 8.68B | |
+23.14% | 3.86B | |
+13.90% | 2.43B | |
-26.46% | 1.84B | |
-11.23% | 1.73B | |
+37.14% | 1.16B | |
+50.75% | 842M | |
-9.17% | 702M | |
-10.92% | 594M |
- Stock Market
- Equities
- AWH Stock
- Stock
- Company VERMILLION INC